nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP2C8—Paclitaxel—ovarian cancer	0.033	0.302	CbGbCtD
Bezafibrate—CYP3A4—Topotecan—ovarian cancer	0.027	0.247	CbGbCtD
Bezafibrate—CYP3A4—Vinorelbine—ovarian cancer	0.019	0.174	CbGbCtD
Bezafibrate—CYP3A4—Paclitaxel—ovarian cancer	0.0134	0.122	CbGbCtD
Bezafibrate—PPARG—Irinotecan—Topotecan—ovarian cancer	0.0127	1	CbGdCrCtD
Bezafibrate—CYP3A4—Docetaxel—ovarian cancer	0.00968	0.0885	CbGbCtD
Bezafibrate—PPARA—embryo—ovarian cancer	0.00965	0.0481	CbGeAlD
Bezafibrate—PPARD—uterine cervix—ovarian cancer	0.00916	0.0457	CbGeAlD
Bezafibrate—PPARD—decidua—ovarian cancer	0.00873	0.0435	CbGeAlD
Bezafibrate—PPARA—epithelium—ovarian cancer	0.00787	0.0393	CbGeAlD
Bezafibrate—CYP3A4—Doxorubicin—ovarian cancer	0.00721	0.066	CbGbCtD
Bezafibrate—PPARD—female reproductive system—ovarian cancer	0.00686	0.0342	CbGeAlD
Bezafibrate—HMGCR—myometrium—ovarian cancer	0.00667	0.0333	CbGeAlD
Bezafibrate—PPARD—female gonad—ovarian cancer	0.00624	0.0312	CbGeAlD
Bezafibrate—PPARD—vagina—ovarian cancer	0.00621	0.031	CbGeAlD
Bezafibrate—PPARA—female reproductive system—ovarian cancer	0.00585	0.0292	CbGeAlD
Bezafibrate—PPARD—testis—ovarian cancer	0.00554	0.0276	CbGeAlD
Bezafibrate—PPARA—female gonad—ovarian cancer	0.00532	0.0265	CbGeAlD
Bezafibrate—PPARG—embryo—ovarian cancer	0.0053	0.0265	CbGeAlD
Bezafibrate—HMGCR—epithelium—ovarian cancer	0.00524	0.0261	CbGeAlD
Bezafibrate—HMGCR—uterine cervix—ovarian cancer	0.00519	0.0259	CbGeAlD
Bezafibrate—HMGCR—decidua—ovarian cancer	0.00495	0.0247	CbGeAlD
Bezafibrate—PPARA—testis—ovarian cancer	0.00472	0.0235	CbGeAlD
Bezafibrate—HMGCR—endometrium—ovarian cancer	0.0047	0.0234	CbGeAlD
Bezafibrate—HMGCR—gonad—ovarian cancer	0.00436	0.0217	CbGeAlD
Bezafibrate—HMGCR—uterus—ovarian cancer	0.00433	0.0216	CbGeAlD
Bezafibrate—PPARG—epithelium—ovarian cancer	0.00433	0.0216	CbGeAlD
Bezafibrate—PPARG—decidua—ovarian cancer	0.00409	0.0204	CbGeAlD
Bezafibrate—PPARD—lymph node—ovarian cancer	0.00401	0.02	CbGeAlD
Bezafibrate—HMGCR—female reproductive system—ovarian cancer	0.00389	0.0194	CbGeAlD
Bezafibrate—SLCO1B1—female reproductive system—ovarian cancer	0.00373	0.0186	CbGeAlD
Bezafibrate—HMGCR—bone marrow—ovarian cancer	0.00367	0.0183	CbGeAlD
Bezafibrate—PPARG—uterus—ovarian cancer	0.00358	0.0178	CbGeAlD
Bezafibrate—HMGCR—female gonad—ovarian cancer	0.00354	0.0177	CbGeAlD
Bezafibrate—HMGCR—vagina—ovarian cancer	0.00352	0.0176	CbGeAlD
Bezafibrate—PPARA—lymph node—ovarian cancer	0.00342	0.0171	CbGeAlD
Bezafibrate—PPARG—female reproductive system—ovarian cancer	0.00322	0.016	CbGeAlD
Bezafibrate—HMGCR—testis—ovarian cancer	0.00314	0.0157	CbGeAlD
Bezafibrate—PPARG—bone marrow—ovarian cancer	0.00304	0.0151	CbGeAlD
Bezafibrate—PPARG—female gonad—ovarian cancer	0.00293	0.0146	CbGeAlD
Bezafibrate—PPARG—vagina—ovarian cancer	0.00291	0.0145	CbGeAlD
Bezafibrate—CYP1A1—epithelium—ovarian cancer	0.00263	0.0131	CbGeAlD
Bezafibrate—CYP1A1—uterine cervix—ovarian cancer	0.00261	0.013	CbGeAlD
Bezafibrate—PPARG—testis—ovarian cancer	0.0026	0.0129	CbGeAlD
Bezafibrate—CYP2C8—endometrium—ovarian cancer	0.00256	0.0128	CbGeAlD
Bezafibrate—Indomethacin—CXCL8—ovarian cancer	0.00228	0.574	CrCbGaD
Bezafibrate—HMGCR—lymph node—ovarian cancer	0.00228	0.0114	CbGeAlD
Bezafibrate—CYP1A1—uterus—ovarian cancer	0.00218	0.0109	CbGeAlD
Bezafibrate—CYP2C8—female reproductive system—ovarian cancer	0.00212	0.0106	CbGeAlD
Bezafibrate—Phosphatase alkaline increased—Docetaxel—ovarian cancer	0.00196	0.00542	CcSEcCtD
Bezafibrate—CYP1A1—female reproductive system—ovarian cancer	0.00196	0.00976	CbGeAlD
Bezafibrate—Urinary tract disorder—Melphalan—ovarian cancer	0.00195	0.0054	CcSEcCtD
Bezafibrate—Urethral disorder—Melphalan—ovarian cancer	0.00194	0.00536	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Paclitaxel—ovarian cancer	0.00193	0.00534	CcSEcCtD
Bezafibrate—CYP2C8—vagina—ovarian cancer	0.00192	0.00956	CbGeAlD
Bezafibrate—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.0019	0.00525	CcSEcCtD
Bezafibrate—Myocardial infarction—Vinorelbine—ovarian cancer	0.00188	0.00522	CcSEcCtD
Bezafibrate—PPARG—lymph node—ovarian cancer	0.00188	0.00938	CbGeAlD
Bezafibrate—Anaemia—Chlorambucil—ovarian cancer	0.00182	0.00505	CcSEcCtD
Bezafibrate—Renal failure acute—Paclitaxel—ovarian cancer	0.00182	0.00503	CcSEcCtD
Bezafibrate—Alopecia—Topotecan—ovarian cancer	0.00178	0.00493	CcSEcCtD
Bezafibrate—CYP1A1—female gonad—ovarian cancer	0.00178	0.00888	CbGeAlD
Bezafibrate—CYP1A1—vagina—ovarian cancer	0.00177	0.00883	CbGeAlD
Bezafibrate—Alopecia—Melphalan—ovarian cancer	0.00175	0.00483	CcSEcCtD
Bezafibrate—CYP2C8—testis—ovarian cancer	0.00171	0.00853	CbGeAlD
Bezafibrate—Muscle spasms—Topotecan—ovarian cancer	0.00169	0.00467	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Docetaxel—ovarian cancer	0.00164	0.00453	CcSEcCtD
Bezafibrate—Anaemia—Topotecan—ovarian cancer	0.00162	0.00449	CcSEcCtD
Bezafibrate—Infection—Chlorambucil—ovarian cancer	0.0016	0.00443	CcSEcCtD
Bezafibrate—Anaemia—Melphalan—ovarian cancer	0.00159	0.0044	CcSEcCtD
Bezafibrate—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00158	0.00436	CcSEcCtD
Bezafibrate—Blood creatinine increased—Paclitaxel—ovarian cancer	0.00157	0.00435	CcSEcCtD
Bezafibrate—Liver function test abnormal—Paclitaxel—ovarian cancer	0.00155	0.00429	CcSEcCtD
Bezafibrate—Alopecia—Vinorelbine—ovarian cancer	0.00153	0.00422	CcSEcCtD
Bezafibrate—Cramp muscle—Paclitaxel—ovarian cancer	0.00151	0.00418	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00151	0.00418	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.00151	0.00418	CcSEcCtD
Bezafibrate—Erythema—Vinorelbine—ovarian cancer	0.0015	0.00416	CcSEcCtD
Bezafibrate—Myalgia—Topotecan—ovarian cancer	0.0015	0.00414	CcSEcCtD
Bezafibrate—Muscular weakness—Paclitaxel—ovarian cancer	0.00148	0.0041	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.00148	0.0041	CcSEcCtD
Bezafibrate—Myalgia—Melphalan—ovarian cancer	0.00146	0.00405	CcSEcCtD
Bezafibrate—Influenza—Paclitaxel—ovarian cancer	0.00145	0.00401	CcSEcCtD
Bezafibrate—CYP3A4—female reproductive system—ovarian cancer	0.00144	0.00716	CbGeAlD
Bezafibrate—Infection—Topotecan—ovarian cancer	0.00142	0.00394	CcSEcCtD
Bezafibrate—Dyspepsia—Chlorambucil—ovarian cancer	0.00142	0.00392	CcSEcCtD
Bezafibrate—Thrombocytopenia—Topotecan—ovarian cancer	0.0014	0.00388	CcSEcCtD
Bezafibrate—Migraine—Docetaxel—ovarian cancer	0.0014	0.00387	CcSEcCtD
Bezafibrate—Bronchitis—Paclitaxel—ovarian cancer	0.00139	0.00386	CcSEcCtD
Bezafibrate—Infection—Melphalan—ovarian cancer	0.00139	0.00386	CcSEcCtD
Bezafibrate—Anaemia—Vinorelbine—ovarian cancer	0.00139	0.00384	CcSEcCtD
Bezafibrate—Pancytopenia—Paclitaxel—ovarian cancer	0.00138	0.00381	CcSEcCtD
Bezafibrate—Pain—Chlorambucil—ovarian cancer	0.00138	0.00381	CcSEcCtD
Bezafibrate—Thrombocytopenia—Melphalan—ovarian cancer	0.00137	0.0038	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00132	0.00366	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Epirubicin—ovarian cancer	0.00132	0.00366	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00132	0.00364	CcSEcCtD
Bezafibrate—Liver function test abnormal—Docetaxel—ovarian cancer	0.00131	0.00363	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00131	0.00361	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00128	0.00355	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00128	0.00355	CcSEcCtD
Bezafibrate—Cramp muscle—Docetaxel—ovarian cancer	0.00128	0.00355	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.00128	0.00355	CcSEcCtD
Bezafibrate—Urticaria—Chlorambucil—ovarian cancer	0.00128	0.00354	CcSEcCtD
Bezafibrate—Myalgia—Vinorelbine—ovarian cancer	0.00128	0.00354	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00128	0.00354	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00127	0.00353	CcSEcCtD
Bezafibrate—Abdominal pain—Chlorambucil—ovarian cancer	0.00127	0.00352	CcSEcCtD
Bezafibrate—Myocardial infarction—Paclitaxel—ovarian cancer	0.00127	0.00351	CcSEcCtD
Bezafibrate—Dyspepsia—Topotecan—ovarian cancer	0.00126	0.00349	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.00125	0.00347	CcSEcCtD
Bezafibrate—Dyspepsia—Melphalan—ovarian cancer	0.00124	0.00342	CcSEcCtD
Bezafibrate—Pain—Topotecan—ovarian cancer	0.00123	0.00339	CcSEcCtD
Bezafibrate—Constipation—Topotecan—ovarian cancer	0.00123	0.00339	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Doxorubicin—ovarian cancer	0.00122	0.00338	CcSEcCtD
Bezafibrate—Infection—Vinorelbine—ovarian cancer	0.00122	0.00337	CcSEcCtD
Bezafibrate—Thrombocytopenia—Vinorelbine—ovarian cancer	0.0012	0.00332	CcSEcCtD
Bezafibrate—Pain—Melphalan—ovarian cancer	0.0012	0.00332	CcSEcCtD
Bezafibrate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00119	0.00328	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Topotecan—ovarian cancer	0.00117	0.00324	CcSEcCtD
Bezafibrate—Pancytopenia—Docetaxel—ovarian cancer	0.00117	0.00323	CcSEcCtD
Bezafibrate—Pharyngitis—Paclitaxel—ovarian cancer	0.00115	0.00319	CcSEcCtD
Bezafibrate—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00115	0.00317	CcSEcCtD
Bezafibrate—CYP1A1—lymph node—ovarian cancer	0.00114	0.00571	CbGeAlD
Bezafibrate—Pruritus—Chlorambucil—ovarian cancer	0.00114	0.00315	CcSEcCtD
Bezafibrate—Urticaria—Topotecan—ovarian cancer	0.00114	0.00315	CcSEcCtD
Bezafibrate—Urethral disorder—Paclitaxel—ovarian cancer	0.00114	0.00315	CcSEcCtD
Bezafibrate—Abdominal pain—Topotecan—ovarian cancer	0.00113	0.00314	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00112	0.00309	CcSEcCtD
Bezafibrate—Urticaria—Melphalan—ovarian cancer	0.00112	0.00309	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.0011	0.00305	CcSEcCtD
Bezafibrate—Diarrhoea—Chlorambucil—ovarian cancer	0.0011	0.00305	CcSEcCtD
Bezafibrate—Erythema multiforme—Paclitaxel—ovarian cancer	0.0011	0.00304	CcSEcCtD
Bezafibrate—Photosensitivity—Epirubicin—ovarian cancer	0.00109	0.00302	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00109	0.00301	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00108	0.00299	CcSEcCtD
Bezafibrate—Myocardial infarction—Docetaxel—ovarian cancer	0.00107	0.00297	CcSEcCtD
Bezafibrate—Vascular purpura—Epirubicin—ovarian cancer	0.00107	0.00297	CcSEcCtD
Bezafibrate—Eczema—Epirubicin—ovarian cancer	0.00107	0.00295	CcSEcCtD
Bezafibrate—Hypersensitivity—Topotecan—ovarian cancer	0.00106	0.00292	CcSEcCtD
Bezafibrate—Pain—Vinorelbine—ovarian cancer	0.00105	0.0029	CcSEcCtD
Bezafibrate—Constipation—Vinorelbine—ovarian cancer	0.00105	0.0029	CcSEcCtD
Bezafibrate—Renal failure acute—Epirubicin—ovarian cancer	0.00104	0.00288	CcSEcCtD
Bezafibrate—Hypersensitivity—Melphalan—ovarian cancer	0.00103	0.00286	CcSEcCtD
Bezafibrate—Alopecia—Paclitaxel—ovarian cancer	0.00103	0.00284	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.00102	0.00282	CcSEcCtD
Bezafibrate—Pruritus—Topotecan—ovarian cancer	0.00101	0.00281	CcSEcCtD
Bezafibrate—Photosensitivity—Doxorubicin—ovarian cancer	0.00101	0.0028	CcSEcCtD
Bezafibrate—Erythema—Paclitaxel—ovarian cancer	0.00101	0.0028	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.001	0.00278	CcSEcCtD
Bezafibrate—Flatulence—Paclitaxel—ovarian cancer	0.000996	0.00276	CcSEcCtD
Bezafibrate—Purpura—Epirubicin—ovarian cancer	0.000995	0.00275	CcSEcCtD
Bezafibrate—Pruritus—Melphalan—ovarian cancer	0.000993	0.00275	CcSEcCtD
Bezafibrate—Vascular purpura—Doxorubicin—ovarian cancer	0.000992	0.00275	CcSEcCtD
Bezafibrate—Eczema—Doxorubicin—ovarian cancer	0.000988	0.00273	CcSEcCtD
Bezafibrate—Diarrhoea—Topotecan—ovarian cancer	0.000981	0.00271	CcSEcCtD
Bezafibrate—Pharyngitis—Docetaxel—ovarian cancer	0.000977	0.0027	CcSEcCtD
Bezafibrate—Urticaria—Vinorelbine—ovarian cancer	0.000974	0.0027	CcSEcCtD
Bezafibrate—Urinary tract disorder—Docetaxel—ovarian cancer	0.000972	0.00269	CcSEcCtD
Bezafibrate—Muscle spasms—Paclitaxel—ovarian cancer	0.000972	0.00269	CcSEcCtD
Bezafibrate—Abdominal pain—Vinorelbine—ovarian cancer	0.000969	0.00268	CcSEcCtD
Bezafibrate—Urethral disorder—Docetaxel—ovarian cancer	0.000965	0.00267	CcSEcCtD
Bezafibrate—Renal failure acute—Doxorubicin—ovarian cancer	0.000962	0.00266	CcSEcCtD
Bezafibrate—Diarrhoea—Melphalan—ovarian cancer	0.00096	0.00266	CcSEcCtD
Bezafibrate—Nausea—Chlorambucil—ovarian cancer	0.000956	0.00265	CcSEcCtD
Bezafibrate—Dizziness—Topotecan—ovarian cancer	0.000948	0.00262	CcSEcCtD
Bezafibrate—Migraine—Epirubicin—ovarian cancer	0.000944	0.00261	CcSEcCtD
Bezafibrate—Anaemia—Paclitaxel—ovarian cancer	0.000934	0.00259	CcSEcCtD
Bezafibrate—Erythema multiforme—Docetaxel—ovarian cancer	0.00093	0.00258	CcSEcCtD
Bezafibrate—Purpura—Doxorubicin—ovarian cancer	0.000921	0.00255	CcSEcCtD
Bezafibrate—Rash—Topotecan—ovarian cancer	0.000904	0.0025	CcSEcCtD
Bezafibrate—Hypersensitivity—Vinorelbine—ovarian cancer	0.000903	0.0025	CcSEcCtD
Bezafibrate—Dermatitis—Topotecan—ovarian cancer	0.000903	0.0025	CcSEcCtD
Bezafibrate—Blood creatinine increased—Epirubicin—ovarian cancer	0.000899	0.00249	CcSEcCtD
Bezafibrate—Headache—Topotecan—ovarian cancer	0.000898	0.00249	CcSEcCtD
Bezafibrate—Liver function test abnormal—Epirubicin—ovarian cancer	0.000886	0.00245	CcSEcCtD
Bezafibrate—Rash—Melphalan—ovarian cancer	0.000885	0.00245	CcSEcCtD
Bezafibrate—Dermatitis—Melphalan—ovarian cancer	0.000884	0.00245	CcSEcCtD
Bezafibrate—Migraine—Doxorubicin—ovarian cancer	0.000874	0.00242	CcSEcCtD
Bezafibrate—Alopecia—Docetaxel—ovarian cancer	0.00087	0.00241	CcSEcCtD
Bezafibrate—Pruritus—Vinorelbine—ovarian cancer	0.000868	0.0024	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000864	0.00239	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000864	0.00239	CcSEcCtD
Bezafibrate—Myalgia—Paclitaxel—ovarian cancer	0.00086	0.00238	CcSEcCtD
Bezafibrate—Erythema—Docetaxel—ovarian cancer	0.000857	0.00237	CcSEcCtD
Bezafibrate—Nausea—Topotecan—ovarian cancer	0.000851	0.00236	CcSEcCtD
Bezafibrate—Gastritis—Epirubicin—ovarian cancer	0.000849	0.00235	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000846	0.00234	CcSEcCtD
Bezafibrate—Muscular weakness—Epirubicin—ovarian cancer	0.000846	0.00234	CcSEcCtD
Bezafibrate—Diarrhoea—Vinorelbine—ovarian cancer	0.000839	0.00232	CcSEcCtD
Bezafibrate—Nausea—Melphalan—ovarian cancer	0.000834	0.00231	CcSEcCtD
Bezafibrate—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000832	0.0023	CcSEcCtD
Bezafibrate—Influenza—Epirubicin—ovarian cancer	0.000829	0.00229	CcSEcCtD
Bezafibrate—Muscle spasms—Docetaxel—ovarian cancer	0.000824	0.00228	CcSEcCtD
Bezafibrate—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00082	0.00227	CcSEcCtD
Bezafibrate—Infection—Paclitaxel—ovarian cancer	0.000819	0.00227	CcSEcCtD
Bezafibrate—Dizziness—Vinorelbine—ovarian cancer	0.000811	0.00224	CcSEcCtD
Bezafibrate—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000808	0.00224	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000799	0.00221	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000799	0.00221	CcSEcCtD
Bezafibrate—Bronchitis—Epirubicin—ovarian cancer	0.000797	0.00221	CcSEcCtD
Bezafibrate—Anaemia—Docetaxel—ovarian cancer	0.000792	0.00219	CcSEcCtD
Bezafibrate—Pancytopenia—Epirubicin—ovarian cancer	0.000788	0.00218	CcSEcCtD
Bezafibrate—Gastritis—Doxorubicin—ovarian cancer	0.000786	0.00217	CcSEcCtD
Bezafibrate—Muscular weakness—Doxorubicin—ovarian cancer	0.000783	0.00217	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000783	0.00217	CcSEcCtD
Bezafibrate—Rash—Vinorelbine—ovarian cancer	0.000773	0.00214	CcSEcCtD
Bezafibrate—Dermatitis—Vinorelbine—ovarian cancer	0.000772	0.00214	CcSEcCtD
Bezafibrate—Headache—Vinorelbine—ovarian cancer	0.000768	0.00213	CcSEcCtD
Bezafibrate—Influenza—Doxorubicin—ovarian cancer	0.000767	0.00212	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000757	0.00209	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000751	0.00208	CcSEcCtD
Bezafibrate—Insomnia—Paclitaxel—ovarian cancer	0.000746	0.00206	CcSEcCtD
Bezafibrate—Bronchitis—Doxorubicin—ovarian cancer	0.000738	0.00204	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000733	0.00203	CcSEcCtD
Bezafibrate—Myalgia—Docetaxel—ovarian cancer	0.000729	0.00202	CcSEcCtD
Bezafibrate—Pancytopenia—Doxorubicin—ovarian cancer	0.000729	0.00202	CcSEcCtD
Bezafibrate—Nausea—Vinorelbine—ovarian cancer	0.000728	0.00202	CcSEcCtD
Bezafibrate—Dyspepsia—Paclitaxel—ovarian cancer	0.000726	0.00201	CcSEcCtD
Bezafibrate—Constipation—Paclitaxel—ovarian cancer	0.000705	0.00195	CcSEcCtD
Bezafibrate—Pain—Paclitaxel—ovarian cancer	0.000705	0.00195	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.0007	0.00194	CcSEcCtD
Bezafibrate—Infection—Docetaxel—ovarian cancer	0.000695	0.00192	CcSEcCtD
Bezafibrate—Thrombocytopenia—Docetaxel—ovarian cancer	0.000685	0.00189	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000678	0.00188	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000674	0.00187	CcSEcCtD
Bezafibrate—Pharyngitis—Epirubicin—ovarian cancer	0.000659	0.00182	CcSEcCtD
Bezafibrate—Urinary tract disorder—Epirubicin—ovarian cancer	0.000655	0.00181	CcSEcCtD
Bezafibrate—Urticaria—Paclitaxel—ovarian cancer	0.000655	0.00181	CcSEcCtD
Bezafibrate—Abdominal pain—Paclitaxel—ovarian cancer	0.000652	0.0018	CcSEcCtD
Bezafibrate—Urethral disorder—Epirubicin—ovarian cancer	0.000651	0.0018	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000637	0.00176	CcSEcCtD
Bezafibrate—Insomnia—Docetaxel—ovarian cancer	0.000632	0.00175	CcSEcCtD
Bezafibrate—Erythema multiforme—Epirubicin—ovarian cancer	0.000628	0.00174	CcSEcCtD
Bezafibrate—Aminohippurate—ABCB1—ovarian cancer	0.000617	0.155	CrCbGaD
Bezafibrate—Dyspepsia—Docetaxel—ovarian cancer	0.000615	0.0017	CcSEcCtD
Bezafibrate—Pharyngitis—Doxorubicin—ovarian cancer	0.00061	0.00169	CcSEcCtD
Bezafibrate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000608	0.00168	CcSEcCtD
Bezafibrate—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000607	0.00168	CcSEcCtD
Bezafibrate—Urethral disorder—Doxorubicin—ovarian cancer	0.000602	0.00167	CcSEcCtD
Bezafibrate—Pain—Docetaxel—ovarian cancer	0.000598	0.00165	CcSEcCtD
Bezafibrate—Constipation—Docetaxel—ovarian cancer	0.000598	0.00165	CcSEcCtD
Bezafibrate—Alopecia—Epirubicin—ovarian cancer	0.000587	0.00162	CcSEcCtD
Bezafibrate—Pruritus—Paclitaxel—ovarian cancer	0.000584	0.00162	CcSEcCtD
Bezafibrate—Erythema multiforme—Doxorubicin—ovarian cancer	0.000581	0.00161	CcSEcCtD
Bezafibrate—Erythema—Epirubicin—ovarian cancer	0.000578	0.0016	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000572	0.00158	CcSEcCtD
Bezafibrate—Flatulence—Epirubicin—ovarian cancer	0.000569	0.00158	CcSEcCtD
Bezafibrate—Indomethacin—ABCB1—ovarian cancer	0.000566	0.142	CrCbGaD
Bezafibrate—Diarrhoea—Paclitaxel—ovarian cancer	0.000564	0.00156	CcSEcCtD
Bezafibrate—Muscle spasms—Epirubicin—ovarian cancer	0.000556	0.00154	CcSEcCtD
Bezafibrate—Abdominal pain—Docetaxel—ovarian cancer	0.000553	0.00153	CcSEcCtD
Bezafibrate—Dizziness—Paclitaxel—ovarian cancer	0.000545	0.00151	CcSEcCtD
Bezafibrate—Alopecia—Doxorubicin—ovarian cancer	0.000543	0.0015	CcSEcCtD
Bezafibrate—Erythema—Doxorubicin—ovarian cancer	0.000535	0.00148	CcSEcCtD
Bezafibrate—Anaemia—Epirubicin—ovarian cancer	0.000534	0.00148	CcSEcCtD
Bezafibrate—Flatulence—Doxorubicin—ovarian cancer	0.000527	0.00146	CcSEcCtD
Bezafibrate—Rash—Paclitaxel—ovarian cancer	0.00052	0.00144	CcSEcCtD
Bezafibrate—Dermatitis—Paclitaxel—ovarian cancer	0.00052	0.00144	CcSEcCtD
Bezafibrate—Headache—Paclitaxel—ovarian cancer	0.000517	0.00143	CcSEcCtD
Bezafibrate—Hypersensitivity—Docetaxel—ovarian cancer	0.000515	0.00143	CcSEcCtD
Bezafibrate—Muscle spasms—Doxorubicin—ovarian cancer	0.000514	0.00142	CcSEcCtD
Bezafibrate—Glyburide—ABCB1—ovarian cancer	0.000512	0.129	CrCbGaD
Bezafibrate—Pruritus—Docetaxel—ovarian cancer	0.000495	0.00137	CcSEcCtD
Bezafibrate—Anaemia—Doxorubicin—ovarian cancer	0.000494	0.00137	CcSEcCtD
Bezafibrate—Myalgia—Epirubicin—ovarian cancer	0.000492	0.00136	CcSEcCtD
Bezafibrate—Nausea—Paclitaxel—ovarian cancer	0.00049	0.00136	CcSEcCtD
Bezafibrate—Diarrhoea—Docetaxel—ovarian cancer	0.000478	0.00132	CcSEcCtD
Bezafibrate—Infection—Epirubicin—ovarian cancer	0.000468	0.0013	CcSEcCtD
Bezafibrate—Dizziness—Docetaxel—ovarian cancer	0.000462	0.00128	CcSEcCtD
Bezafibrate—Thrombocytopenia—Epirubicin—ovarian cancer	0.000462	0.00128	CcSEcCtD
Bezafibrate—Myalgia—Doxorubicin—ovarian cancer	0.000455	0.00126	CcSEcCtD
Bezafibrate—Rash—Docetaxel—ovarian cancer	0.000441	0.00122	CcSEcCtD
Bezafibrate—Dermatitis—Docetaxel—ovarian cancer	0.00044	0.00122	CcSEcCtD
Bezafibrate—Headache—Docetaxel—ovarian cancer	0.000438	0.00121	CcSEcCtD
Bezafibrate—Infection—Doxorubicin—ovarian cancer	0.000433	0.0012	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00043	0.00119	CcSEcCtD
Bezafibrate—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000427	0.00118	CcSEcCtD
Bezafibrate—Insomnia—Epirubicin—ovarian cancer	0.000427	0.00118	CcSEcCtD
Bezafibrate—Nausea—Docetaxel—ovarian cancer	0.000415	0.00115	CcSEcCtD
Bezafibrate—Dyspepsia—Epirubicin—ovarian cancer	0.000415	0.00115	CcSEcCtD
Bezafibrate—Pain—Epirubicin—ovarian cancer	0.000403	0.00112	CcSEcCtD
Bezafibrate—Constipation—Epirubicin—ovarian cancer	0.000403	0.00112	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000398	0.0011	CcSEcCtD
Bezafibrate—Insomnia—Doxorubicin—ovarian cancer	0.000395	0.00109	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000386	0.00107	CcSEcCtD
Bezafibrate—Dyspepsia—Doxorubicin—ovarian cancer	0.000384	0.00106	CcSEcCtD
Bezafibrate—Urticaria—Epirubicin—ovarian cancer	0.000375	0.00104	CcSEcCtD
Bezafibrate—Constipation—Doxorubicin—ovarian cancer	0.000373	0.00103	CcSEcCtD
Bezafibrate—Pain—Doxorubicin—ovarian cancer	0.000373	0.00103	CcSEcCtD
Bezafibrate—Abdominal pain—Epirubicin—ovarian cancer	0.000373	0.00103	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000357	0.000987	CcSEcCtD
Bezafibrate—Hypersensitivity—Epirubicin—ovarian cancer	0.000347	0.000962	CcSEcCtD
Bezafibrate—Urticaria—Doxorubicin—ovarian cancer	0.000347	0.000959	CcSEcCtD
Bezafibrate—Abdominal pain—Doxorubicin—ovarian cancer	0.000345	0.000955	CcSEcCtD
Bezafibrate—Pruritus—Epirubicin—ovarian cancer	0.000334	0.000923	CcSEcCtD
Bezafibrate—Diarrhoea—Epirubicin—ovarian cancer	0.000323	0.000893	CcSEcCtD
Bezafibrate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000321	0.00089	CcSEcCtD
Bezafibrate—Dizziness—Epirubicin—ovarian cancer	0.000312	0.000863	CcSEcCtD
Bezafibrate—Pruritus—Doxorubicin—ovarian cancer	0.000309	0.000854	CcSEcCtD
Bezafibrate—Diarrhoea—Doxorubicin—ovarian cancer	0.000299	0.000826	CcSEcCtD
Bezafibrate—Rash—Epirubicin—ovarian cancer	0.000297	0.000823	CcSEcCtD
Bezafibrate—Dermatitis—Epirubicin—ovarian cancer	0.000297	0.000822	CcSEcCtD
Bezafibrate—Headache—Epirubicin—ovarian cancer	0.000295	0.000818	CcSEcCtD
Bezafibrate—Dizziness—Doxorubicin—ovarian cancer	0.000289	0.000799	CcSEcCtD
Bezafibrate—Nausea—Epirubicin—ovarian cancer	0.00028	0.000775	CcSEcCtD
Bezafibrate—Rash—Doxorubicin—ovarian cancer	0.000275	0.000761	CcSEcCtD
Bezafibrate—Dermatitis—Doxorubicin—ovarian cancer	0.000275	0.000761	CcSEcCtD
Bezafibrate—Headache—Doxorubicin—ovarian cancer	0.000273	0.000756	CcSEcCtD
Bezafibrate—Nausea—Doxorubicin—ovarian cancer	0.000259	0.000717	CcSEcCtD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000189	0.000607	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000188	0.000601	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PGR—ovarian cancer	0.000186	0.000597	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PPP2R1A—ovarian cancer	0.000184	0.00059	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—YAP1—ovarian cancer	0.000181	0.000581	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.00018	0.000577	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00018	0.000577	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000179	0.000575	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—PTEN—ovarian cancer	0.000179	0.000574	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—FASN—ovarian cancer	0.000177	0.000568	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—BRIP1—ovarian cancer	0.000177	0.000568	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PPP1CC—ovarian cancer	0.000177	0.000568	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—SLC5A5—ovarian cancer	0.000175	0.000559	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PARP1—ovarian cancer	0.000173	0.000555	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000171	0.000549	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—ovarian cancer	0.000171	0.000546	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—SLC2A1—ovarian cancer	0.000169	0.00054	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—YAP1—ovarian cancer	0.000166	0.000531	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000165	0.000529	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000164	0.000526	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP2—ovarian cancer	0.000163	0.000522	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP1B1—ovarian cancer	0.000162	0.000518	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00016	0.000513	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYTB—ovarian cancer	0.00016	0.000511	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—IL6—ovarian cancer	0.000159	0.000508	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000158	0.000505	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—IL6—ovarian cancer	0.000156	0.0005	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000156	0.0005	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NME2—ovarian cancer	0.000155	0.000497	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000155	0.000496	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—YAP1—ovarian cancer	0.000153	0.00049	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ESR1—ovarian cancer	0.000148	0.000474	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—FASN—ovarian cancer	0.000148	0.000473	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—SLC5A5—ovarian cancer	0.000145	0.000466	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000144	0.000462	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PPP2R1A—ovarian cancer	0.000143	0.000459	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—ERBB2—ovarian cancer	0.000143	0.000457	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000143	0.000457	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NME2—ovarian cancer	0.000142	0.000456	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MYC—ovarian cancer	0.000141	0.000452	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PPP2R1A—ovarian cancer	0.00014	0.00045	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—SLC2A1—ovarian cancer	0.00014	0.00045	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MET—ovarian cancer	0.00014	0.000448	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—BRIP1—ovarian cancer	0.00014	0.000447	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	0.00014	0.000447	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000138	0.00044	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6ST—ovarian cancer	0.000137	0.000439	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—FASN—ovarian cancer	0.000135	0.000433	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP1B1—ovarian cancer	0.000135	0.000431	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PGR—ovarian cancer	0.000133	0.000428	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ABCB1—ovarian cancer	0.000133	0.000426	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SLC5A5—ovarian cancer	0.000133	0.000426	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000132	0.000422	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—TYMS—ovarian cancer	0.000131	0.000419	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ESR1—ovarian cancer	0.000131	0.000418	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000129	0.000414	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SLC2A1—ovarian cancer	0.000128	0.000411	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000126	0.000403	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000125	0.000401	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CTNNB1—ovarian cancer	0.000125	0.0004	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PARP1—ovarian cancer	0.000124	0.000397	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000124	0.000396	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP1B1—ovarian cancer	0.000123	0.000394	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP9—ovarian cancer	0.000122	0.000392	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—ovarian cancer	0.000122	0.000391	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000122	0.000391	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000121	0.000387	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPP2R1A—ovarian cancer	0.000119	0.000382	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—YAP1—ovarian cancer	0.000119	0.000381	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000119	0.000381	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000118	0.000377	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP2—ovarian cancer	0.000117	0.000374	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—IL6—ovarian cancer	0.000112	0.000358	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ABCB1—ovarian cancer	0.000111	0.000355	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—ovarian cancer	0.00011	0.000352	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PPP2R1A—ovarian cancer	0.000109	0.00035	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—TYMS—ovarian cancer	0.000109	0.000349	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—STAT3—ovarian cancer	0.000109	0.000349	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000109	0.000348	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—NRAS—ovarian cancer	0.000109	0.000348	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—ovarian cancer	0.000107	0.000344	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000107	0.000344	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CAV1—ovarian cancer	0.000105	0.000337	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK3—ovarian cancer	0.000104	0.000333	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000103	0.000331	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—ERBB2—ovarian cancer	0.000102	0.000328	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000102	0.000326	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ABCB1—ovarian cancer	0.000101	0.000325	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PPP2R1A—ovarian cancer	0.000101	0.000322	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000101	0.000322	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYTB—ovarian cancer	0.0001	0.000321	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—TYMS—ovarian cancer	9.96e-05	0.000319	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ESR1—ovarian cancer	9.95e-05	0.000319	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK1—ovarian cancer	9.89e-05	0.000317	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—ovarian cancer	9.89e-05	0.000317	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.85e-05	0.000315	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.78e-05	0.000313	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—FASN—ovarian cancer	9.69e-05	0.00031	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CG—ovarian cancer	9.6e-05	0.000307	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC5A5—ovarian cancer	9.53e-05	0.000305	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—YAP1—ovarian cancer	9.36e-05	0.0003	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—ovarian cancer	9.35e-05	0.000299	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.26e-05	0.000297	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SLC2A1—ovarian cancer	9.21e-05	0.000295	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYTB—ovarian cancer	9.17e-05	0.000294	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.01e-05	0.000289	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.97e-05	0.000287	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—ovarian cancer	8.95e-05	0.000287	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP1B1—ovarian cancer	8.83e-05	0.000283	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CAV1—ovarian cancer	8.78e-05	0.000281	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—ovarian cancer	8.77e-05	0.000281	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPP1CC—ovarian cancer	8.75e-05	0.00028	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—BRIP1—ovarian cancer	8.75e-05	0.00028	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CD—ovarian cancer	8.44e-05	0.00027	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.38e-05	0.000268	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.14e-05	0.000261	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CAV1—ovarian cancer	8.03e-05	0.000257	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—BRIP1—ovarian cancer	8.02e-05	0.000257	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPP1CC—ovarian cancer	8.02e-05	0.000257	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CG—ovarian cancer	7.99e-05	0.000256	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—ovarian cancer	7.94e-05	0.000254	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—ovarian cancer	7.88e-05	0.000252	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PPP2R1A—ovarian cancer	7.83e-05	0.000251	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—ovarian cancer	7.8e-05	0.00025	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.79e-05	0.000249	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NRAS—ovarian cancer	7.78e-05	0.000249	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—ovarian cancer	7.7e-05	0.000247	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.67e-05	0.000246	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NME2—ovarian cancer	7.64e-05	0.000245	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—FASN—ovarian cancer	7.63e-05	0.000244	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—ovarian cancer	7.6e-05	0.000243	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	7.51e-05	0.00024	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK3—ovarian cancer	7.45e-05	0.000239	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CB—ovarian cancer	7.35e-05	0.000235	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CG—ovarian cancer	7.31e-05	0.000234	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCB1—ovarian cancer	7.27e-05	0.000233	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	7.25e-05	0.000232	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TYMS—ovarian cancer	7.14e-05	0.000229	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR1—ovarian cancer	7.13e-05	0.000228	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.1e-05	0.000227	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK1—ovarian cancer	7.09e-05	0.000227	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—ovarian cancer	7.09e-05	0.000227	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CD—ovarian cancer	7.03e-05	0.000225	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—ovarian cancer	7.01e-05	0.000225	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MAPK3—ovarian cancer	6.98e-05	0.000224	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	6.95e-05	0.000223	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—ovarian cancer	6.79e-05	0.000217	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—ovarian cancer	6.7e-05	0.000214	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CD—ovarian cancer	6.43e-05	0.000206	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.37e-05	0.000204	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTEN—ovarian cancer	6.35e-05	0.000203	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	6.16e-05	0.000197	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.13e-05	0.000196	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CB—ovarian cancer	6.12e-05	0.000196	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—YAP1—ovarian cancer	5.87e-05	0.000188	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.84e-05	0.000187	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.81e-05	0.000186	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CAV1—ovarian cancer	5.75e-05	0.000184	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCB1—ovarian cancer	5.72e-05	0.000183	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—ovarian cancer	5.69e-05	0.000182	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TYMS—ovarian cancer	5.62e-05	0.00018	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CB—ovarian cancer	5.6e-05	0.000179	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.5e-05	0.000176	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—ovarian cancer	5.45e-05	0.000174	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—YAP1—ovarian cancer	5.38e-05	0.000172	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.32e-05	0.00017	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MAPK3—ovarian cancer	5.32e-05	0.00017	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTEN—ovarian cancer	5.29e-05	0.000169	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CG—ovarian cancer	5.24e-05	0.000168	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—ovarian cancer	5.17e-05	0.000166	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.1e-05	0.000163	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—ovarian cancer	5.03e-05	0.000161	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYTB—ovarian cancer	4.92e-05	0.000158	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTEN—ovarian cancer	4.84e-05	0.000155	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—FASN—ovarian cancer	4.78e-05	0.000153	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—ovarian cancer	4.71e-05	0.000151	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC5A5—ovarian cancer	4.7e-05	0.000151	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.68e-05	0.00015	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CD—ovarian cancer	4.61e-05	0.000148	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SLC2A1—ovarian cancer	4.54e-05	0.000146	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CAV1—ovarian cancer	4.53e-05	0.000145	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—ovarian cancer	4.48e-05	0.000144	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.45e-05	0.000142	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—FASN—ovarian cancer	4.38e-05	0.00014	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP1B1—ovarian cancer	4.36e-05	0.00014	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.33e-05	0.000139	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC5A5—ovarian cancer	4.31e-05	0.000138	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BRIP1—ovarian cancer	4.3e-05	0.000138	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPP1CC—ovarian cancer	4.3e-05	0.000138	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SLC2A1—ovarian cancer	4.17e-05	0.000133	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	4.13e-05	0.000132	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.08e-05	0.000131	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CB—ovarian cancer	4.01e-05	0.000129	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP1B1—ovarian cancer	3.99e-05	0.000128	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	3.86e-05	0.000124	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.84e-05	0.000123	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK3—ovarian cancer	3.81e-05	0.000122	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—ovarian cancer	3.73e-05	0.00012	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—ovarian cancer	3.71e-05	0.000119	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—ovarian cancer	3.66e-05	0.000117	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	3.63e-05	0.000116	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—ovarian cancer	3.59e-05	0.000115	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCB1—ovarian cancer	3.59e-05	0.000115	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	3.54e-05	0.000113	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.52e-05	0.000113	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TYMS—ovarian cancer	3.52e-05	0.000113	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTEN—ovarian cancer	3.47e-05	0.000111	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—ovarian cancer	3.41e-05	0.000109	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCB1—ovarian cancer	3.29e-05	0.000105	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TYMS—ovarian cancer	3.23e-05	0.000103	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	3.16e-05	0.000101	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—ovarian cancer	3.05e-05	9.77e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—YAP1—ovarian cancer	2.89e-05	9.25e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CAV1—ovarian cancer	2.84e-05	9.09e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—ovarian cancer	2.79e-05	8.93e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTEN—ovarian cancer	2.73e-05	8.75e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.71e-05	8.69e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CAV1—ovarian cancer	2.6e-05	8.34e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CG—ovarian cancer	2.59e-05	8.28e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—ovarian cancer	2.57e-05	8.23e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.49e-05	7.96e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—ovarian cancer	2.45e-05	7.84e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CG—ovarian cancer	2.37e-05	7.59e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FASN—ovarian cancer	2.35e-05	7.54e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.32e-05	7.41e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CD—ovarian cancer	2.27e-05	7.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.24e-05	7.16e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.14e-05	6.87e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.08e-05	6.67e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—ovarian cancer	2e-05	6.4e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CB—ovarian cancer	1.98e-05	6.35e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	1.93e-05	6.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.9e-05	6.09e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CB—ovarian cancer	1.82e-05	5.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.77e-05	5.65e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TYMS—ovarian cancer	1.73e-05	5.55e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTEN—ovarian cancer	1.71e-05	5.48e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—ovarian cancer	1.57e-05	5.04e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTEN—ovarian cancer	1.57e-05	5.03e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CAV1—ovarian cancer	1.4e-05	4.47e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.27e-05	4.08e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.21e-05	3.87e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.12e-05	3.58e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.11e-05	3.55e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—ovarian cancer	9.87e-06	3.16e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CB—ovarian cancer	9.75e-06	3.12e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—ovarian cancer	9.05e-06	2.9e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTEN—ovarian cancer	8.43e-06	2.7e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—ovarian cancer	5.94e-06	1.9e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—ovarian cancer	4.86e-06	1.56e-05	CbGpPWpGaD
